Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Alzheimers disease (AD) is a major challenge for the individual affected, society at large and there only modest effective drug treatment. We believe that a central problem in AD is the deteriorating fuel supply to the brain (mostly the sugar, glucose) and this impairment appears long before the onset of memory and cognitive problems emerge. We believe that attempting to correct this fuel problem will be part of any successful therapy for AD. We are developing an alternative fuel to glucose for the brain in the form of a ketogenic supplement based on medium chain triglycerides such as those present in coconut oil. We will measure brain ketone metabolism in AD and how it responds to a ketogenic drink. Hight brain ketone uptake is expected to improve global brain energy metabolism, thereby helping memory and cognitive problems. We have cutting-edge brain imaging methods with which to better understand how the AD brain responds to an improved brain fuel supply provide by ketones.
Stephen Cunnane
Etienne Croteau
Fondation Vitae
Medicine
Information and communications technologies
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.